Dashboard
Manage Tickers

RPTXRepare Therapeutics Inc.

Nasdaq reparerx.com


$ 3.31 $ -0.08 (-2.37 %)    

Friday, 28-Jun-2024 15:59:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 3.3
$ 3.36
$ 0.00 x 0
$ 0.00 x 0
$ 3.26 - $ 3.38
$ 2.98 - $ 13.85
117,539
na
145.28M
$ 0.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

repare-therapeutics-shares-initial-data-from-phase-1-minotaur-trial-evaluating-lunresertib-in-combination-with-folfiri-at-esmo-gi-cancers-congress-2024
Repare Therapeutics Shares Initial Data Fr...
06/26/2024 14:33:20

Overall response of 18.2% in heavily pretreated patients across gastrointestinal tumors with target alterations regardless of p...

foundation-medicine-taps-repare-therapeutics-to-provide-genomic-profiling-services-to-support-clinical-trials-and-to-develop-companion-diagnostic-for-lunresertib
Foundation Medicine Taps Repare Therapeuti...
06/12/2024 11:17:29

 Foundation Medicine, Inc., today announced that it has formed a collaboration with Repare Therapeutics, a leading clinical-sta...

repare-therapeutics-doses-first-patient-in-camonsertib-monotherapy-non-small-cell-lung-cancer-expansion-of-tresr-clinical-trial
Repare Therapeutics Doses First Patient in...
06/10/2024 11:09:17

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a leading clinical-stage precision oncology...

hc-wainwright--co-reiterates-buy-on-repare-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Repa...
06/05/2024 10:31:38

HC Wainwright & Co. analyst Robert Burns reiterates Repare Therapeutics (NASDAQ:RPTX) with a Buy and maintains $10 price...

repare-therapeutics-receives-fda-fast-track-designation-for-lunresertib-in-combination-with-camonsertib-for-platinum-resistant-ovarian-cancer
Repare Therapeutics Receives FDA Fast Trac...
06/04/2024 20:09:55

hc-wainwright--co-reiterates-buy-on-repare-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Repa...
05/30/2024 11:01:13

HC Wainwright & Co. analyst Robert Burns reiterates Repare Therapeutics (NASDAQ:RPTX) with a Buy and maintains $10 price...

repare-therapeutics-lunresertib-rp-6306-phase-1-minotaur-study-data-to-be-presented-at-esmo-2024
Repare Therapeutics' Lunresertib (RP-6306)...
05/29/2024 11:19:35

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a leading clinical-stage precision oncology...

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

why-ringcentral-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why RingCentral Shares Are Trading Higher ...
05/08/2024 12:07:56

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

repare-therapeutics-q1-eps-030-beats-002-estimate-sales-5240m-beat-3840m-estimate
Repare Therapeutics Q1 EPS $0.30 Beats $0....
05/07/2024 21:01:05

Repare Therapeutics (NASDAQ:RPTX) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $...

repare-therapeutics-and-debiopharm-have-dosed-the-first-patient-in-phase-11b-mythic-trial-investigating-lunresertib-in-combination-with-debio-0123
Repare Therapeutics And Debiopharm Have Do...
04/30/2024 11:11:38

roches-lymphoma-drug-with-chemo-extends-survival-in-pretreated-patients
Roche's Lymphoma Drug With Chemo Extends S...
04/15/2024 12:56:25

Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + G...

hc-wainwright--co-reiterates-buy-on-repare-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Repa...
03/08/2024 12:03:44

HC Wainwright & Co. analyst Robert Burns reiterates Repare Therapeutics (NASDAQ:RPTX) with a Buy and maintains $10 price...

recap-repare-therapeutics-q4-earnings
Recap: Repare Therapeutics Q4 Earnings
02/28/2024 14:40:07

hc-wainwright--co-reiterates-buy-on-repare-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Repa...
02/21/2024 11:44:09

HC Wainwright & Co. analyst Robert Burns reiterates Repare Therapeutics (NASDAQ:RPTX) with a Buy and maintains $10 price...

repare-therapeutics-has-dosed-the-first-patient-in-phase-1--lions-trial-evaluating-rp-1664-for-the-monotherapy-treatment-of-adult-and-adolescent-patients-enriched-for-trim37-high-solid-tumors
Repare Therapeutics Has Dosed The First Pa...
02/15/2024 12:16:47

hc-wainwright--co-maintains-buy-on-repare-therapeutics-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Repar...
02/14/2024 11:47:24

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics (NASDAQ:RPTX) with a Buy and lowers the price tar...

roche-terminates-cancer-drug-pact-with-repare-therapeutics-its-second-walkout-within-a-month
Roche Terminates Cancer Drug Pact With Rep...
02/13/2024 13:43:35

Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone a...

Core News & Articles
Repare Therapeutics To Regain Global Devel...
02/12/2024 21:10:01

Roche notified Repare that, effective May 7, 2024, it is terminating its worldwide license and collaboration agreement for the ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)